A New Injectable Device for Overactive Bladder
An Injectable Electrode to Better Isolate the Posterior Tibial Nerve to Treat OAB
['FUNDING_R01'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-11194347
This project is developing a new, tiny injectable device to help people with overactive bladder who haven't found relief from other treatments.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-11194347 on ClinicalTrials.gov |
What this research studies
Many people with overactive bladder (OAB) experience frequent, urgent needs to urinate, which significantly impacts their daily lives. While current treatments like lifestyle changes, bladder training, and medications can help, they often don't provide complete relief, and some people find them ineffective or have side effects. Existing nerve stimulation devices for OAB can be costly, complex, and sometimes don't target the nerve precisely. This project aims to create a simpler, more accurate injectable device that can better stimulate the nerve in the ankle to improve OAB symptoms.
Who could benefit from this research
Good fit: This research is most relevant for patients who experience severe overactive bladder symptoms that have not improved with standard treatments or who have experienced side effects from current therapies.
Not a fit: Patients whose overactive bladder symptoms are well-managed by current treatments or who are not interested in device-based therapies may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this new device could offer a more effective, less complicated, and more precise treatment option for individuals living with overactive bladder.
How similar studies have performed: Existing nerve stimulation devices for overactive bladder have shown some success, but this project proposes a novel engineering approach to improve targeting and reduce complications.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LUDWIG, KIP A — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: LUDWIG, KIP A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.